Novartis pays $310 million upfront to buy IFM Tre adding portfolio of experimental antiinflammatory drugs httpswww.firstwordpharma.comnode1632487Â $NVS

Novartis pays $310 million upfront to buy IFM Tre, adding portfolio of experimental anti-inflammatory drugs https://www.firstwordpharma.com/node/1632487  $NVS

04:16 EDT 1 Apr 2019 | FirstWord Pharma

Novartis pays $310 million upfront to buy IFM Tre, adding portfolio of experimental anti-inflammatory drugs https://www.firstwordpharma.com/node/1632487  $NVS

More From BioPortfolio on "Novartis pays $310 million upfront to buy IFM Tre, adding portfolio of experimental anti-inflammatory drugs https://www.firstwordpharma.com/node/1632487  $NVS"